Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Ruprecht

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Nature Communications|September 24, 2016
A bead-based western for high-throughput cellular signal transduction analysesFridolin Treindl, Benjamin Ruprecht, Yvonne Beiter, et al.
ACS Chemical Biology|October 22, 2016
Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase DrugsStephanie Heinzlmeir, Denis Kudlinzki, Sridhar Sreeramulu, et al.
Journal of Proteome Research|February 10, 2015
Optimized chemical proteomics assay for kinase inhibitor profilingGuillaume Médard, Fiona Pachl, Benjamin Ruprecht, et al.
Molecular and Cellular Biology|September 11, 2019
Omomyc Reveals New Mechanisms To Inhibit the MYC OncogeneMark J Demma, Claudio Mapelli, Angie Sun, et al.
Nature Communications|July 21, 2020
Proteome activity landscapes of tumor cell lines determine drug responsesMartin Frejno, Chen Meng, Benjamin Ruprecht, et al.
Molecular & Cellular Proteomics : MCP|August 10, 2014
Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomicsDominic Helm, Johannes P C Vissers, Christopher J Hughes, et al.
Molecular Systems Biology|November 5, 2017
Pharmacoproteomic characterisation of human colon and rectal cancerMartin Frejno, Riccardo Zenezini Chiozzi, Mathias Wilhelm, et al.
Nature Chemical Biology|July 22, 2020
A mass spectrometry-based proteome map of drug action in lung cancer cell linesBenjamin Ruprecht, Julie Di Bernardo, Zhao Wang, et al.
Nature Chemical Biology|August 15, 2020
Publisher Correction: A mass spectrometry-based proteome map of drug action in lung cancer cell linesBenjamin Ruprecht, Julie Di Bernardo, Zhao Wang, et al.
Nature Communications|October 6, 2022
Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometryTom Dixon, Derek MacPherson, Barmak Mostofian, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Nature Communications|September 24, 2016
A bead-based western for high-throughput cellular signal transduction analysesFridolin Treindl, Benjamin Ruprecht, Yvonne Beiter, et al.
ACS Chemical Biology|October 22, 2016
Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase DrugsStephanie Heinzlmeir, Denis Kudlinzki, Sridhar Sreeramulu, et al.
Journal of Proteome Research|February 10, 2015
Optimized chemical proteomics assay for kinase inhibitor profilingGuillaume Médard, Fiona Pachl, Benjamin Ruprecht, et al.
Molecular and Cellular Biology|September 11, 2019
Omomyc Reveals New Mechanisms To Inhibit the MYC OncogeneMark J Demma, Claudio Mapelli, Angie Sun, et al.
Nature Communications|July 21, 2020
Proteome activity landscapes of tumor cell lines determine drug responsesMartin Frejno, Chen Meng, Benjamin Ruprecht, et al.
Molecular & Cellular Proteomics : MCP|August 10, 2014
Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomicsDominic Helm, Johannes P C Vissers, Christopher J Hughes, et al.
Molecular Systems Biology|November 5, 2017
Pharmacoproteomic characterisation of human colon and rectal cancerMartin Frejno, Riccardo Zenezini Chiozzi, Mathias Wilhelm, et al.
Nature Chemical Biology|July 22, 2020
A mass spectrometry-based proteome map of drug action in lung cancer cell linesBenjamin Ruprecht, Julie Di Bernardo, Zhao Wang, et al.
Nature Chemical Biology|August 15, 2020
Publisher Correction: A mass spectrometry-based proteome map of drug action in lung cancer cell linesBenjamin Ruprecht, Julie Di Bernardo, Zhao Wang, et al.
Nature Communications|October 6, 2022
Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometryTom Dixon, Derek MacPherson, Barmak Mostofian, et al.
Pageof 4